Rockefeller University

New York, New York, United States
Purpose
to evaluate the safety, pharmacokinetics and antiretroviral effects of two human anti-HIV monoclonal antibodies, alone and in combination in HIV-infected and HIV-uninfected individuals
Grantee
Division
Global Health
Date
OCTOBER 2013
Region served
GLOBAL
Committed amount
$18,995,777
Grant topic
HIV
Duration (months)
102
Grantee location
New York, New York, United States
Related work

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.